Literature DB >> 8429217

The use of palmitate-conjugated protein A for coating cells with artificial receptors which facilitate intercellular interactions.

S A Kim1, J S Peacock.   

Abstract

A method is described in which palmitate-conjugated protein A (pal-protein A) incorporated onto cell membranes is used to anchor antibodies on the surface of cells. Pal-protein A was stabilized on the cell surfaces via insertion of the hydrophobic palmitate moieties into the phospholipid bilayer of the plasma membrane. This membrane-associated pal-protein A retained its binding affinity for the Fc region of rabbit immunoglobulin G (IgG) molecules. Using this system, cells can be coated with antibody (Ab) molecules of a desired specificity that can serve as artificial receptors for soluble or cell surface antigens (Ags). In this report, we show that A22.E10 T hybridoma cells coated with rabbit anti-mouse IgG (RaMIgG) exhibited increased adhesiveness to surface IgG positive mouse B cells. A high level of heterotypic intercellular conjugation was observed in cells coated with specific artificial receptors as compared to cells coated with nonspecific artificial receptors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8429217     DOI: 10.1016/0022-1759(93)90258-9

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  21 in total

Review 1.  Synthetic cell surface receptors for delivery of therapeutics and probes.

Authors:  David Hymel; Blake R Peterson
Journal:  Adv Drug Deliv Rev       Date:  2012-02-25       Impact factor: 15.470

Review 2.  Programming Cell-Cell Interactions through Non-genetic Membrane Engineering.

Authors:  Clifford M Csizmar; Jacob R Petersburg; Carston R Wagner
Journal:  Cell Chem Biol       Date:  2018-06-14       Impact factor: 8.116

Review 3.  Strategies for cell membrane functionalization.

Authors:  James Pk Armstrong; Adam W Perriman
Journal:  Exp Biol Med (Maywood)       Date:  2016-05

4.  Cell surface glycoengineering improves selectin-mediated adhesion of mesenchymal stem cells (MSCs) and cardiosphere-derived cells (CDCs): Pilot validation in porcine ischemia-reperfusion model.

Authors:  Chi Y Lo; Brian R Weil; Beth A Palka; Arezoo Momeni; John M Canty; Sriram Neelamegham
Journal:  Biomaterials       Date:  2015-09-25       Impact factor: 12.479

Review 5.  Engineering the Surface of Therapeutic "Living" Cells.

Authors:  Jooyeon Park; Brenda Andrade; Yongbeom Seo; Myung-Joo Kim; Steven C Zimmerman; Hyunjoon Kong
Journal:  Chem Rev       Date:  2018-01-16       Impact factor: 60.622

Review 6.  Antigen-presenting cell engineering. The molecular toolbox.

Authors:  M L Tykocinski; D R Kaplan; M E Medof
Journal:  Am J Pathol       Date:  1996-01       Impact factor: 4.307

7.  A liposome-based ion release impedance sensor for biological detection.

Authors:  Gregory L Damhorst; Cartney E Smith; Eric M Salm; Magdalena M Sobieraj; Hengkan Ni; Hyunjoon Kong; Rashid Bashir
Journal:  Biomed Microdevices       Date:  2013-10       Impact factor: 2.838

Review 8.  New designs for cancer vaccine and artificial veto cells: an emerging palette of protein paints.

Authors:  Mark L Tykocinski; Aoshuang Chen; Jui-Han Huang; Matthew C Weber; Guoxing Zheng
Journal:  Immunol Res       Date:  2003       Impact factor: 2.829

9.  Targeting mesenchymal stem cells to activated endothelial cells.

Authors:  In Kap Ko; Thomas J Kean; James E Dennis
Journal:  Biomaterials       Date:  2009-04-17       Impact factor: 12.479

10.  Palmitate-derivatized human IL-2: a potential anticancer immunotherapeutic of low systemic toxicity.

Authors:  Sharon H Chou; Aditya V Shetty; Yajun Geng; Lipeng Xu; Gnanasekar Munirathinam; Anne Pipathsouk; Isaiah Tan; Timothy Morris; Bin Wang; Aoshuang Chen; Guoxing Zheng
Journal:  Cancer Immunol Immunother       Date:  2012-11-04       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.